China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm owns a GMP-certified plant and production facilities and has the capacity to produce 21 different NMPA-approved medicines, 14 NMPA-approved health supplement products and 8 hemp derivative products in soft capsule, hard capsule, tablet, granule, oral liquid forms. These products address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.
Follow-Up Questions
Qui est le CEO de China Health Industries Holdings Inc ?
Mr. Xin Sun est le Chairman of the Board de China Health Industries Holdings Inc, il a rejoint l'entreprise depuis 2007.
Quelle est la performance du prix de l'action CHHE ?
Le prix actuel de CHHE est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de China Health Industries Holdings Inc ?
China Health Industries Holdings Inc appartient à l'industrie Consumer products et le secteur est Consumer Staples
Quelle est la capitalisation boursière de China Health Industries Holdings Inc ?
La capitalisation boursière actuelle de China Health Industries Holdings Inc est de $0
